1
|
Zhang Y, Gong YY, Tang YL, Bai YS, Yang K, Chen HY, Zhang QA, Wang JA, Zhu YF, Li HY, Liu QM, Lin JR, Wu WY. Clinical efficacy of microwave in the treatment of axillary osmidrosis and primary hyperhidrosis. Dermatol Ther 2022; 35:e15657. [PMID: 35726636 DOI: 10.1111/dth.15657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 06/15/2022] [Accepted: 06/17/2022] [Indexed: 11/26/2022]
Abstract
BACKGROUND Axillary osmidrosis(AO) and primary hyperhidrosis(PH) are common diseases, but there are still difficulties in treatment. Microwave therapy may become a new method. OBJECTIVE To evaluate long-time efficacy of patients with AO or PH treated by microwave. To discuss possible mechanism of microwave therapy by combining results of clinical and pathological. METHODS Ten AO or PH patients with moderate or severe level were selected as subjects, and each subject received microwave treatment of bilateral armpits. The follow-up period lasted two years,and the changes of perspiration and odor were evaluated in subjective and objective ways. Each subject took skin biopsy in the treatment area before and after treatment or each follow-up. HE and immunohistochemical staining were performed. RESULTS Both subjective and objective index reflected the significant improvement of AO and PH after treatment(P<0.05). Dermatology life quality index score decreased by 10.4±4.6(P<0.05). The number of apocrine glands decreased significantly after treatment, and most of them changed from secretory phase to quiescent phase. CONCLUSIONS Microwave therapy can destroy apocrine sweat glands, reduce number of functional glands, so as to improve symptoms of AO and PH and elevate quality of life, which is safe, effective and stable. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Yue Zhang
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Yi-Yi Gong
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Yu-Long Tang
- State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences,Fudan University, Shanghai, China
| | - Yan-Shuang Bai
- Department of Dermatology, Shanghai Jing'an District Central Hospital, Shanghai, China
| | - Kai Yang
- Department of Dermatology, Shanghai Jing'an District Central Hospital, Shanghai, China
| | - Hu-Yan Chen
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Qiao-An Zhang
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Ji-An Wang
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Yi-Fei Zhu
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Hai-Yang Li
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Qing-Mei Liu
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Jin-Ran Lin
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Wen-Yu Wu
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.,Department of Dermatology, Shanghai Jing'an District Central Hospital, Shanghai, China
| |
Collapse
|